IL6 and acute coronary syndrome: Increased levels of IL-6 stimulate the liver to synthesize and secrete CRP [31], which functions as a pro-atherosclerotic factor [33] and serves as a risk marker for mortality from acute coronary syndrome (ACS) after 30–90 days [25,34].